Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 141-149

  Kalantar Zadeh, Kamyar ^a   Rodriguez, Rudolph A ^b   Humphreys, Michael H ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

End stage renal disease; Ferritin; Inflammation; Iron; Malnutrition inflammation complex syndrome; Protein energy malnutrition

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; IRON; IRON DEXTRAN;

ADULT; AGED; ANALYSIS OF VARIANCE; ANEMIA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DOSE RESPONSE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTHESIS; INFLAMMATION; IRON DEFICIENCY; IRON OVERLOAD; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BIOLOGICAL MARKERS; FEMALE; FERRITINS; HUMANS; INFLAMMATION; IRON; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; RENAL DIALYSIS; SYNDROME;

EID: 0346656654     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg493     Document Type: Article

References (24)

1. Kalantar-Zadeh K, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 1995; 26: 292-299
2. National Kidney Foundation I, Kidney-Dialysis Outcome Quality Initiative. K/DOQI clinical practice guidelines: anemia. Am J Kidney Dis 2001; 37 [Suppl 1]
3. Kalender B, Mutlu B, Ersoz M, Kalkan A, Yilmaz A. The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients. Int J Clin Pract 2002; 56: 505-508
4. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH.c Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 2001; 37: 564-572
5. Rogers JT. Ferritin translation by interleukin-land interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996; 87: 2525-2537
6. Kalantar-Zadeh K, Ikizler A, Block G, Avram M, Kopple J. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003
7. Kalantar-Zadeh K, McAllister C, Lehn R, Lee G, Nissenson A, Kopple J. Effect of malnutrition-inflammation complex syndrome on erythropoietin hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003; in press
8. Kalantar-Zadeh K, Kleiner M, Dunne E et al. Total iron-binding capacity - estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 1998; 31: 263-272
9. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 1999; 14: 1732-1738
10. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-1263
11. Kattamis A, Dinopoulos A, Ladis V, Berdousi H, Kattamis C. Variations of ferritin levels over a period of 15 years as a compliance chelation index in thalassemic patients. Am J Hematol 2001; 68: 221-224
12. Mavrogeni SI, Gotsis ED, Markussis V et al. T2 relaxation time study of iron overload in b-thalassemia. Magma 1998; 6: 7-12
13. Barany P, Eriksson LC, Hultcrantz R, Pettersson E, Bergstrom J. Serum ferritin and tissue iron in anemic dialysis patients. Miner Electrolyte Metab 1997; 23: 273-276
14. Worwood M. Ferritin. Blood Rev 1990; 4: 259-269
15. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Anton PE, Munro HN. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1. J Biol Chem 1990; 265: 14572-14578
16. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
17. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808
18. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group. Kidney Int 2000; 58: 346-352
19. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 63-72
20. Feldman HI, Santanna J, Guo W et al. Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 2002; 13: 734-744
21. Eschbach JW, Adamson JW. Iron overload in renal failure patients: changes since the introduction of erythropoietin therapy. Kidney Int Suppl 1999; 69: S35-S43
22. Barany P, Divino Filho JC, Bergstrom J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997; 29: 565-568
23. Kaysen GA, Don BR. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int Suppl 2003; 94-97
24. Drueke T, Witko-Sarsat V, Massy Z et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002; 106: 2212-2217